ECSP003572A - ORALLY ACTIVE ANDROGENS - Google Patents

ORALLY ACTIVE ANDROGENS

Info

Publication number
ECSP003572A
ECSP003572A ECSP003572A ECSP003572A EC SP003572 A ECSP003572 A EC SP003572A EC SP003572 A ECSP003572 A EC SP003572A EC SP003572 A ECSP003572 A EC SP003572A
Authority
EC
Ecuador
Prior art keywords
alkyl
hydrogen
halogen
orally active
acyl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Dirk Leysen
Hubert Jan Jozef Loozen
Van Der Jaap Louw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003572 priority Critical patent/ECSP003572A/en
Publication of ECSP003572A publication Critical patent/ECSP003572A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Nuevos adrógenos oralmente activos son derivados de A14-nandrolona 7-A-sustituidos. Los compuestos satisfacen la fórmula general: (gráfico), donde R1 es O, (H;H), (H,OR), NOR, siendo R hidrógeno, (C1-6) alquilo o (C1-6) acilo; R2 se selecciona del grupo consistente en (C2-4) alquilo, (C2-4) alquenilo o (C2-4) alquinilo, cada uno opcionalmente sustituido por halógeno; o R2 es ciclopropilo o ciclopropenilo, cada uno opcionalmente sustituido por (C1-2) alquilo o halógeno; R3 es hidrógeno, (C1-2) alquilo halógeno; R3 es hidrógeno (C1-2) alquilo o etinilo; R4 es (C1-2) alquilo; R5 es hidrógeno o (C1-15) acilo; y las lineas de puntos indican enlaces opcionales.Novel orally active adrogens are 7-A-substituted A14-nandrolone derivatives. The compounds satisfy the general formula: (graph), where R1 is O, (H; H), (H, OR), NOR, where R is hydrogen, (C1-6) alkyl or (C1-6) acyl; R2 is selected from the group consisting of (C2-4) alkyl, (C2-4) alkenyl, or (C2-4) alkynyl, each optionally substituted by halogen; or R2 is cyclopropyl or cyclopropenyl, each optionally substituted by (C1-2) alkyl or halogen; R3 is hydrogen, (C1-2) alkyl halogen; R3 is hydrogen (C1-2) alkyl or ethynyl; R4 is (C1-2) alkyl; R5 is hydrogen or (C1-15) acyl; and the dotted lines indicate optional links.

ECSP003572 2000-07-13 2000-07-13 ORALLY ACTIVE ANDROGENS ECSP003572A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003572 ECSP003572A (en) 2000-07-13 2000-07-13 ORALLY ACTIVE ANDROGENS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003572 ECSP003572A (en) 2000-07-13 2000-07-13 ORALLY ACTIVE ANDROGENS

Publications (1)

Publication Number Publication Date
ECSP003572A true ECSP003572A (en) 2000-09-22

Family

ID=42041185

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003572 ECSP003572A (en) 2000-07-13 2000-07-13 ORALLY ACTIVE ANDROGENS

Country Status (1)

Country Link
EC (1) ECSP003572A (en)

Similar Documents

Publication Publication Date Title
AR024746A1 (en) ORALALLY ACTIVE ANDROGENS.
ES2269465T3 (en) HETEROCICLICAL COMPOUNDS OF UNION TO CHEMIOQUINE RECEPTORS.
CO5031253A1 (en) RECEIVING ANTAGONISTS Y5 OF NEUROPEPTIDES PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK1489090T3 (en) Hitherto unknown pseudoerythromycin derivatives
ATE418554T1 (en) 1-ACYL-PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
NO20022857L (en) New P2X7 Receptor Agonists for Use in the Treatment of Inflammatory, Immune or Cardiovascular Diseases
NO20071642L (en) N-Benzenesulfonyl-substituted anilino-pyrimidine analogs
CY1105907T1 (en) NEW 1,2,4-THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR REGULATORS
NO20040100L (en) New compounds such as anti-inflammatory, immunomodulatory and anti-proliferative agents
CY1105233T1 (en) 1,2,4-THIADIAZOLE CATION DERIVATIVES AS MELANOCORTIN RECEPTOR REGULATORS
AR034268A1 (en) COMPOUNDS DERIVED FROM PIPERIDINE, ITS USE IN PREPARATION OF MEDICINES, PHARMACEUTICAL COMPOSITION, TREATMENT METHOD AND PROCESS FOR PREPARATION
NO20062894L (en) 6-alkenyl and 6-phenylalkyl-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors
NO20034289D0 (en) N- (2-arylethylbenzylamines as antagonists of the 5-HT6 receptor)
DK1337518T3 (en) Piperazinylpyrazine Compounds as Antagonists of the Serotonin-5-HT2 Receptor
CO5700824A2 (en) NEW USEFUL HETEROCICLIC COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE296826T1 (en) PYRAZOLO(1,5)PYRIDINE DERIVATIVES
HUP0301607A2 (en) Heterocyclic compound containing nitrogen atoms having selective neurokinin anatgonist effect pharmaceutical compositions containing them and their use
EA200301142A1 (en) DERIVATIVES OF HETEROCYCLILOXY-, -TIOOXY-AND-AMINOBENZAZOL AS A LYHANDS OF 5-HYDROXITRIPTAMINE-6
DE60236218D1 (en) CCR5 antagonists useful for the treatment of AIDS
BR0014151A (en) Components for stable formulation, compositions and methods of washing clothes using the same
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
EA200600694A1 (en) DISULPHID, SULPHIDE, SULPHOXIDE AND SULPHONE DERIVATIVES OF CYCLIC SUGARS AND THEIR APPLICATION
NO20034667L (en) Arylsulfonamides as antivirals
BRPI0409376A (en) indene derivatives as pharmaceutical agents
NO20050871L (en) 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors